Sign in

gouthamnarla

@gouthamnarla.bsky.social
112 followers 239 following 4 posts

physician scientist, professor of medicine, drug hunter, biotech entrepreneur, father, husband, lover of food, wine, and golf

PostsRepliesMedia
gouthamnarla @gouthamnarla.bsky.social · 16/09/2026
JCI Insight - Stabilization of the PP2A-B56α complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML insight.jci.org/articles/vie...
insight.jci.org
JCI Insight - Stabilization of the PP2A-B56α complex overcomes venetoclax-azacitidine resistance by impairing OXPHOS in AML
011
Reposted by gouthamnarla
gouthamnarla @gouthamnarla.bsky.social · 24/02/2026
The protein phosphatase 2A-B56α complex regulates N-Myc degradation in neuroblastoma - Journal of Biological Chemistry www.jbc.org/article/S002... excited to share new research for our group identifying a novel approach to target a major driver of pediatric neuroblastoma
jbc.org
The protein phosphatase 2A-B56α complex regulates N-Myc degradation in neuroblastoma
High-risk neuroblastoma is one of the most common and deadliest pediatric solid tumors. Proliferation, differentiation, and treatment resistance have been linked to the amplification of MYCN. Although...
044
gouthamnarla @gouthamnarla.bsky.social · 24/02/2026
The protein phosphatase 2A-B56α complex regulates N-Myc degradation in neuroblastoma - Journal of Biological Chemistry www.jbc.org/article/S002... excited to share new research for our group identifying a novel approach to target a major driver of pediatric neuroblastoma
jbc.org
The protein phosphatase 2A-B56α complex regulates N-Myc degradation in neuroblastoma
High-risk neuroblastoma is one of the most common and deadliest pediatric solid tumors. Proliferation, differentiation, and treatment resistance have been linked to the amplification of MYCN. Although...
044
Reposted by gouthamnarla
Journal of Clinical Investigation @jci.org · 04/12/2025
Molecular glue as a new therapeutic strategy in metastatic KRAS-mutant lung cancer @gouthamnarla.bsky.social & team combined a PP2A molecular glue with RAS/MAPK inhibitors to restore tumor-suppressor activity & overcome drug resistance in mice with metastatic KRAS-driven NSCLC: buff.ly/1HzFVe5
072
gouthamnarla @gouthamnarla.bsky.social · 23/10/2025
Abstract B051: Discovery of SW-3431, a first-in-class molecular glue activator with potent and selective anti-tumor activity in PPP2R1A mutant cancers url: aacrjournals.org/mct/article/...
aacrjournals.org
Abstract B051: Discovery of SW-3431, a first-in-class molecular glue activator with potent and selective anti-tumor activity in PPP2R1A mutant cancers
AbstractUterine cancer is the only cancer type for which survival has fallen in the past four decades. This past year, uterine cancer deaths surpassed ovarian cancer for the first time: making uterine...
041
Reposted by gouthamnarla
Caitlin O'Connor, PhD @pharmacocaitlin.bsky.social · 05/02/2025
Our new paper describing how mutations to the PP2A gene PPP2R1A drive high-grade uterine cancers is out now in this issue of Cancer Research by @theaacr.bsky.social aacrjournals.org/cancerres/ar...
aacrjournals.org
Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer
Elevated IGFBP2 secretion by uterine cancer cells with heterozygous PPP2R1A mutations supports tumor progression and confers a vulnerability to IGFBP2/IGF1R inhibition as a therapeutic approach for th...
061
Reposted by gouthamnarla
STITCHES Medicine - the Best of Medical Research @medicine.stitches.today · 23/10/2025
Molecular Glue Boosts PP2A, Overcoming Resistance to RAS/MAPK Inhibitors in KRAS-Mutant Lung Cancer, Enhancing Survival Rates. by Raines B, Tseng-Rogenski S (...) Narla G et 14 al. in J Clin Invest #MedSky 👉 get more here 📖 read the article: www.jci.org/articles/view/193790
052
gouthamnarla @gouthamnarla.bsky.social · 21/10/2025
Exciting new finding about the role of PP2A molecular glues in overcoming resistant to broad classes of MAPK inhibitors in KRAS driven cancers JCI - A PP2A molecular glue overcomes ras/mapk inhibitor resistance in kras-mutant non-small cell lung cancer www.jci.org/articles/vie...
jci.org
JCI - A PP2A molecular glue overcomes ras/mapk inhibitor resistance in kras-mutant non-small cell lung cancer
092